[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100639905":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":18,"centralContacts":19,"locations":18,"responsibleParty":25,"collaborators":18,"id":27,"slug":18,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":31,"acronym":18,"eligibilityCriteria":32,"healthyVolunteers":33,"sex":34,"minAge":35,"maxAge":18,"enrollmentInfo":36,"targetDuration":18,"studyType":39,"phases":40,"briefSummary":42,"conditions":43,"keywords":45,"overallStatus":47,"whyStopped":18,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":52,"completionDateStruct":54,"leadSponsor":56,"locationsCount":18},{"fullName":5,"class":6},"Beijing Anzhen Hospital","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Single-lead patch ECG recorder","EXPERIMENTAL","All enrolled participants will wear a single-lead patch ECG recorder for 7 consecutive days. The device continuously records cardiac electrical activity, which is wirelessly transmitted to a central database for real-time analysis. AF episodes detected will be reviewed by the clinical team and communicated to the participant's primary care physician for further management.",[13],"Device: Single-lead patch ECG recorder",[15],{"type":16,"name":9,"description":11,"armGroupLabels":17,"otherNames":18},"DEVICE",[9],null,[20],{"name":21,"role":22,"phone":23,"phoneExt":18,"email":24},"Song Zuo, MD","CONTACT","+8618801427775","song_zuo@126.com",{"type":26,"investigatorFullName":18,"investigatorTitle":18,"investigatorAffiliation":18,"oldNameTitle":18,"oldOrganization":18},"SPONSOR","100639905",false,"NCT07627672","Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community","Effectiveness of Patch-Electrocardiogram Recorders in Screening for Atrial Fibrillation in Elderly People in the Chinese Community: A Prospective Multicenter Study","Inclusion Criteria:\n\n* Age ≥60 years\n* No prior diagnosis of atrial fibrillation\n* Able to understand the study purpose and willing to provide written informed consent\n* No severe cardiac disease, acute illness, or contraindication to ECG monitoring\n* Able to wear the patch ECG device and comply with continuous monitoring requirements\n\nExclusion Criteria:\n\n* Severe cognitive impairment or inability to cooperate with follow-up assessments\n* Pregnant or breastfeeding women\n* Previously diagnosed with atrial fibrillation and already receiving treatment",true,"ALL","60 Years",{"count":37,"type":38},30000,"ESTIMATED","INTERVENTIONAL",[41],"NA","This prospective, multicenter, single-arm study evaluates the effectiveness of a single-lead patch electrocardiogram (ECG) recorder in screening for atrial fibrillation (AF) among community-dwelling elderly individuals aged ≥60 years in China. Participants will undergo 7 days of continuous ECG monitoring, followed by annual follow-up for up to 10 years to assess long-term outcomes including stroke, heart failure, and death.",[44],"Atrial Fibrillation",[46],"Atrial fibrillation; AF screening; Patch ECG; Wearable ECG; Elderly; Community screening; China; FINDING-AF","NOT_YET_RECRUITING","2026-05-31",{"date":50,"type":51},"2026-06-04","ACTUAL",{"date":53,"type":38},"2026-09-01",{"date":55,"type":38},"2036-09-30",{"name":5,"class":6}]